• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

如何设计推进剂吸入器的气溶胶颗粒性质和生物制药性能。

How to engineer aerosol particle properties and biopharmaceutical performance of propellant inhalers.

机构信息

Institute of Pharmaceutical Science, King's College London, London SE1 9NH, UK.

School of Chemistry, University of Bristol, Bristol BS8 1TS, UK.

出版信息

Int J Pharm. 2023 Mar 5;634:122676. doi: 10.1016/j.ijpharm.2023.122676. Epub 2023 Feb 3.

DOI:10.1016/j.ijpharm.2023.122676
PMID:36738807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10685293/
Abstract

Given the environmental compulsion to reformulate pressurised metered dose inhalers (pMDI) using new propellants with lower global warming potential, this study investigated how non-volatile excipients can be used to engineer aerosol particle microphysics and drug release. The dynamics of change in particle size, wetting and physical state were measured for single particles (glycerol/ethanol/beclomethasone dipropionate; BDP) in the aerosol phase at different relative humidity (RH) using an electrodynamic balance. BDP dissolution rates were compared for aerosols from pMDI containing different ratios of BDP:glycerol or BDP:isopropyl myristate (IPM). In 45 % RH, ethanol loss was followed by evaporation of condensed water to generate spherical particles with solid inclusions or compact irregular-shaped solid particles, according to the presence or absence of glycerol. In RH > 95 %, condensed water did not evaporate and BDP formed solid inclusions in water/glycerol or water droplets. Varying the non-volatile component, 0-50 % w/w, in pMDI resulted in a concentration-dependent 4-8-fold reduction in BDP dissolution rate. These findings demonstrate that non-volatile excipients provide a means of engineering aerosol properties and, modifying the rate of drug release from aerosol medicines. We also demonstrated differences between particles formed in vitro in ambient humidity versus higher humidity, more like that encountered during oral inhalation.

摘要

鉴于环境压力需要用全球变暖潜能值较低的新型推进剂来重新配方压力定量吸入器(pMDI),本研究探讨了如何使用非挥发性赋形剂来设计气溶胶颗粒微观物理学和药物释放。使用电动天平在不同相对湿度(RH)下测量了单个颗粒(甘油/乙醇/丙酸倍氯米松;BDP)在气溶胶相中的粒径、润湿和物理状态变化的动力学。比较了含有不同比例 BDP:甘油或 BDP:肉豆蔻酸异丙酯(IPM)的 pMDI 产生的气雾剂中 BDP 的溶解速率。在 45% RH 下,随着乙醇的损失,浓缩水蒸发,生成含有固体包裹物的球形颗粒或含有致密不规则固体颗粒,这取决于是否存在甘油。在 RH>95%下,浓缩水不会蒸发,BDP 在水/甘油或水滴中形成固体包裹物。在 pMDI 中,非挥发性成分(0-50% w/w)的变化导致 BDP 溶解速率呈浓度依赖性降低 4-8 倍。这些发现表明,非挥发性赋形剂提供了一种设计气溶胶性质的手段,并可调节气雾剂药物的释放速率。我们还证明了在环境湿度下与在较高湿度下(更类似于口服吸入期间遇到的湿度)形成的颗粒之间的差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ed/10685293/a30d3d2cfa8e/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ed/10685293/2a1d0a5e453b/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ed/10685293/5b8b77e1d9b7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ed/10685293/e9c3d43fd053/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ed/10685293/23dfbf32bbc4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ed/10685293/6551ef296d05/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ed/10685293/024d60aa64c3/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ed/10685293/a30d3d2cfa8e/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ed/10685293/2a1d0a5e453b/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ed/10685293/5b8b77e1d9b7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ed/10685293/e9c3d43fd053/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ed/10685293/23dfbf32bbc4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ed/10685293/6551ef296d05/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ed/10685293/024d60aa64c3/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ed/10685293/a30d3d2cfa8e/gr6.jpg

相似文献

1
How to engineer aerosol particle properties and biopharmaceutical performance of propellant inhalers.如何设计推进剂吸入器的气溶胶颗粒性质和生物制药性能。
Int J Pharm. 2023 Mar 5;634:122676. doi: 10.1016/j.ijpharm.2023.122676. Epub 2023 Feb 3.
2
Towards the bioequivalence of pressurised metered dose inhalers 1: design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with and without glycerol as a non-volatile excipient.朝着压力定量吸入器的生物等效性迈进 1:设计和特性研究具有和不具有甘油作为非挥发性赋形剂的等效的丙酸倍氯米松吸入器。
Eur J Pharm Biopharm. 2014 Jan;86(1):31-7. doi: 10.1016/j.ejpb.2013.02.014. Epub 2013 Mar 21.
3
Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers.溶液加压吸入器产生的固体颗粒气溶胶的物理化学性质和溶解速率的差异。
Int J Pharm. 2014 Apr 25;465(1-2):42-51. doi: 10.1016/j.ijpharm.2014.01.033. Epub 2014 Jan 31.
4
Towards the bioequivalence of pressurised metered dose inhalers 2. Aerodynamically equivalent particles (with and without glycerol) exhibit different biopharmaceutical profiles in vitro.朝着压力定量吸入器 2 的生物等效性迈进。在体外,空气动力学等效颗粒(含甘油和不含甘油)表现出不同的生物药剂学特征。
Eur J Pharm Biopharm. 2014 Jan;86(1):38-45. doi: 10.1016/j.ejpb.2013.02.020. Epub 2013 Mar 22.
5
Humidity affects the morphology of particles emitted from beclomethasone dipropionate pressurized metered dose inhalers.湿度会影响丙酸倍氯米松压力定量吸入器所释放颗粒的形态。
Int J Pharm. 2017 Mar 30;520(1-2):207-215. doi: 10.1016/j.ijpharm.2017.01.062. Epub 2017 Feb 3.
6
In vitro investigation of the effect of ambient humidity on regional delivered dose with solution and suspension MDIs.体外研究环境湿度对溶液和混悬型 MDIs 局部递送剂量的影响。
J Aerosol Med Pulm Drug Deliv. 2013 Aug;26(4):215-22. doi: 10.1089/jamp.2012.0991. Epub 2012 Oct 24.
7
The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study.机械通气患者使用氯氟烃驱动与氢氟烷烃驱动的丙酸倍氯米松气雾剂的输送情况:一项实验室研究。
Respir Care. 2003 Nov;48(11):1025-32.
8
Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.不含氯氟烃的丙酸倍氯米松超细气雾剂的长期安全性和有效性
Ann Allergy Asthma Immunol. 2001 May;86(5):557-65. doi: 10.1016/S1081-1206(10)62905-5.
9
A pilot study to assess lung deposition of HFA-beclomethasone and CFC-beclomethasone from a pressurized metered dose inhaler with and without add-on spacers and using varying breathhold times.一项评估装有和不装附加储雾器的压力定量气雾剂装置中 HFA-倍氯米松和 CFC-倍氯米松肺沉积的初步研究,以及使用不同的屏气时间。
J Aerosol Med Pulm Drug Deliv. 2010 Dec;23(6):355-61. doi: 10.1089/jamp.2009.0783. Epub 2010 Jun 24.
10
The effect of actuator nozzle designs on the electrostatic charge generated in pressurised metered dose inhaler aerosols.促动器喷嘴设计对压力定量吸入气雾剂中产生的静电荷的影响。
Pharm Res. 2015 Apr;32(4):1237-48. doi: 10.1007/s11095-014-1529-6. Epub 2014 Oct 1.

本文引用的文献

1
Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar Series.制定口服药品的临床相关溶出度规范(CRDSs):虚拟网络研讨会系列
Pharmaceutics. 2022 May 7;14(5):1010. doi: 10.3390/pharmaceutics14051010.
2
iBCS: 2. Mechanistic Modeling of Pulmonary Availability of Inhaled Drugs versus Critical Product Attributes.iBCS:2. 吸入药物肺部利用度的机制模型与关键产品属性。
Mol Pharm. 2022 Jul 4;19(7):2040-2047. doi: 10.1021/acs.molpharmaceut.2c00112. Epub 2022 May 24.
3
iBCS: 1. Principles and Framework of an Inhalation-Based Biopharmaceutics Classification System.
iBCS:1. 吸入型生物药剂学分类系统的原理和框架。
Mol Pharm. 2022 Jul 4;19(7):2032-2039. doi: 10.1021/acs.molpharmaceut.2c00113. Epub 2022 May 16.
4
Water Uptake by Evaporating pMDI Aerosol Prior to Inhalation Affects Both Regional and Total Deposition in the Respiratory System.吸入前蒸发的定量吸入气雾剂(pMDI)的水分摄取会影响呼吸系统中的局部和总沉积。
Pharmaceutics. 2021 Jun 24;13(7):941. doi: 10.3390/pharmaceutics13070941.
5
The Climate is Changing for Metered-Dose Inhalers and Action is Needed.定量吸入器的气候正在改变,需要采取行动。
Drug Des Devel Ther. 2020 Jul 29;14:3043-3055. doi: 10.2147/DDDT.S262141. eCollection 2020.
6
Studies of competing evaporation rates of multiple volatile components from a single binary-component aerosol droplet.关于单个二元组分气溶胶液滴中多种挥发性成分竞争蒸发速率的研究。
Phys Chem Chem Phys. 2019 May 15;21(19):9709-9719. doi: 10.1039/c9cp01158g.
7
Assessing the airborne survival of bacteria in populations of aerosol droplets with a novel technology.评估新型技术下气溶胶液滴中细菌的空气传播存活能力。
J R Soc Interface. 2019 Jan 31;16(150):20180779. doi: 10.1098/rsif.2018.0779.
8
Ranking in Vitro Dissolution of Inhaled Micronized Drug Powders including a Candidate Drug with Two Different Particle Sizes.吸入式微粉化药物粉末(包括一种具有两种不同粒径的候选药物)的体外溶出度排名。
Mol Pharm. 2018 Nov 5;15(11):5319-5326. doi: 10.1021/acs.molpharmaceut.8b00796. Epub 2018 Oct 22.
9
Pulmonary aerosol delivery and the importance of growth dynamics.肺部气溶胶递送与生长动力学的重要性。
Ther Deliv. 2017 Dec;8(12):1051-1061. doi: 10.4155/tde-2017-0093.
10
Experimental and computational study of the effect of breath-actuated mechanism built in the NEXThaler dry powder inhaler.实验与计算研究内置在 NEXThaler 干粉吸入器中的呼吸驱动机制的影响。
Int J Pharm. 2017 Nov 25;533(1):225-235. doi: 10.1016/j.ijpharm.2017.09.057. Epub 2017 Sep 21.